Fact CheckerSign in

NCT07858838Not yet recruiting

Using AI-Assisted Cameras to Track Hand Exercises in Scleroderma Patients

Effectiveness of an AI-Assisted Camera-Based Markerless Exercise Tracking System in Individuals With Scleroderma and Hand Involvement

Source: ClinicalTrials.gov · Last updated 14 Oct 2026

Brief summary (registry, in English)

The objective of this study is to investigate the effects of a camera-based, AI-supported markerless exercise tracking system on hand functions and psychosocial status in patients with Systemic Scleroderma (SSc), in comparison to a traditional face-to-face, physiotherapist-supervised exercise program. It is hypothesized that the AI-based autonomous telerehabilitation intervention will yield statistically and clinically significant improvements in hand mobility, grip strength, and quality of life in SSc patients, achieving outcomes that are similar or superior to those of traditional in-clinic interventions.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
29 Sept 2026
Start date
Nov 2026
Primary completion date
Apr 2027
Lead sponsor
Istanbul University - Cerrahpasa
NCT number
NCT07858838

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From Nov 2026 to the primary completion date, Apr 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Major orthopedic surgery of the upper extremity or wrist within the past 1 year

Other illness

  • Active severe digital ulcers (grade 3 or higher), fingertip gangrene, severe tissue ischemia, or active hand infections
  • Comorbid neurological disorders affecting hand function (e.g., severe peripheral neuropathy, stroke, Parkinson's disease, cervical radiculopathy, or ALS)
  • Advanced cardiopulmonary conditions precluding regular exercise participation (e.g., advanced pulmonary arterial hypertension or interstitial lung disease)

Other

  • Severe primary osteoarthritis or rheumatoid arthritis of the hands
  • Inability to adhere to the 8-week intervention protocol

Who the study is looking for

  • Definitive diagnosis of Systemic Sclerosis (SSc) according to the 2013 ACR/EULAR classification criteria
  • Clinically significant limitation of hand and finger mobility that impairs basic activities of daily living
  • Age between 18 and 65 years
  • Stable medical regimen (no major changes in DMARDs, vasodilators, or immunosuppressive therapies within the preceding 3 months)
  • Sufficient cognitive, visual, and auditory capacity to follow on-screen instructions
  • Access to a personal computer or smart device, a standard webcam, and a stable internet connection

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
İstanbul Üniversitesi-Cerrahpaşa Bakırköy Yerleşkesi
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.